Finance

Lists
4587:TYO
Peptidream Inc
Â¥1,101.50
+7.25%
(+74.50) 1D
Aug 20, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4587...
Open
Â¥1,048
High
Â¥1,114
Low
Â¥1,047
Mkt. cap
143.21B
Avg. vol.
941.05K
Volume
1.50M
52-wk high
Â¥1,818
52-wk low
Â¥906
EPS
-Â¥28
Shares outstanding
123.37M
No. of employees
763
Open
Â¥1,048
High
Â¥1,114
Low
Â¥1,047
Mkt. cap
143.21B
Avg. vol.
941.05K
Volume
1.50M
52-wk high
Â¥1,818
52-wk low
Â¥906
EPS
-Â¥28
Shares outstanding
123.37M
No. of employees
763
About Peptidream Inc
CEO-
Employees763
FoundedJul 3, 2006
HeadquartersKawasaki, Kanagawa, Japan
SectorBiotechnology
Websitepeptidream.com
Last report
Aug 12, 2026
Fiscal period
Q2 2026
EPS / Est. (JPY)
- / -
Revenue / Est. (JPY)
4.46B / 5.68B
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
4.31B
5.66B
4.76B
4.46B
Cost of goods sold
2.64B
2.98B
2.74B
2.52B
Cost of revenue
2.64B
2.98B
2.74B
2.52B
Research and development expenses
1.16B
1.72B
1.23B
1.41B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.93B
1.44B
1.93B
1.91B
Operating expense
3.10B
3.59B
3.17B
3.33B
Total operating expenses
5.75B
6.56B
5.91B
5.86B
Operating income
-1.43B
-899.88M
-1.14B
-1.39B
Other non operating income
1.00K
-
-1.00K
-
EBT including unusual items
-1.48B
-971.25M
-1.20B
-1.46B
EBT excluding unusual items
-1.48B
-917.25M
-1.20B
-1.46B
Income tax expense
-382.38M
-439.59M
-347.24M
-313.12M
Effective tax rate
25.89%
45.26%
28.89%
21.48%
Other operating expenses
4.35M
102.59M
7.47M
13.71M
Net income
-1.09B
-531.66M
-854.90M
-1.14B
Net profit margin
-25.38%
-9.39%
-17.94%
-25.65%
Earnings per share
-
-
-
-
Interest and investment income
49.79M
102.96M
94.78M
40.28M
Interest expense
-74.98M
-
-155.02M
-103.72M
Net interest expenses
-25.19M
102.96M
-60.24M
-63.44M
Depreciation and amortization charges
-
324.00M
-
-
EBITDA
-913.87M
-367.66M
-598.09M
-937.85M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps